Natural products to drugs: natural product derived compounds in clinical trials
Top Cited Papers
- 8 March 2005
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 22 (2) , 162-195
- https://doi.org/10.1039/b402985m
Abstract
Covering: 31st December 2004 Natural product and natural product-derived compounds that are being evaluated in clinical trials or in registration (current 31 December 2004) have been reviewed. Natural product derived drugs launched in the United States of America, Europe and Japan since 1998 and new natural product templates discovered since 1990 are discussed.Keywords
This publication has 604 references indexed in Scilit:
- Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDSJAMA, 2004
- NMR Spectroscopy Tools for Structure‐Aided Drug DesignAngewandte Chemie International Edition in English, 2003
- Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug DesignAngewandte Chemie International Edition in English, 2003
- Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adultsEuropean Archives of Oto-Rhino-Laryngology, 2003
- Phase I and pharmacokinetic study of anhydrovinblastine every 3 weeks in patients with refractory solid tumorsCancer Chemotherapy and Pharmacology, 2003
- HomoharringtonineCancer, 2001
- Antitumor compounds from tunicatesMedicinal Research Reviews, 2000
- Statistical Investigation into the Structural Complementarity of Natural Products and Synthetic CompoundsAngewandte Chemie International Edition in English, 1999
- Combinatorial Synthesis of Small Organic MoleculesAngewandte Chemie International Edition in English, 1996
- Epothilone A and B—Novel 16‐Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in SolutionAngewandte Chemie International Edition in English, 1996